SCHEMBL15065448

SCHEMBL15065448

CCCCC(CCC)c1cc(-c2cc(C(CCC)CCCC)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.37
CYP2C19 P33261 5/20 0.37
ALOX15 P16050 3/20 0.37
CYP2D6 P10635 2/20 0.37
TP53 P04637 2/20 0.37
CYP1A2 P05177 4/20 0.36
GAA P10253 3/20 0.36
ATM Q13315 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
XBP1 P17861 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NR5A2 O00482 1/20 0.35
NR5A1 Q13285 1/20 0.35
CA2 P00918 3/20 0.35
CA1 P00915 2/20 0.35
HPN P05981 1/20 0.35
MAPT P10636 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35
TSHR P16473 3/20 0.35
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065029 0.94 CYP2C9 (0.41) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL15065071 0.91 GAA (0.39) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL17781754 0.88 CYP2C9 (0.39) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL27607951 0.86 CA2 (0.40) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL15064994 0.83 CYP1A2 (0.40) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL2293474 0.82 ALOX15 (0.40) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL15064911 0.79 CYP1A2 (0.39) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL21553306 0.78 ERN1 (0.38) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL15065053 0.78 CYP1A2 (0.38) CYP2C9CYP2C19ALOX15CYP2D6TP53
SCHEMBL17453957 0.77 NR1I2 (0.42) CYP2C9CYP2C19ALOX15CYP2D6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797938-B1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2016-06-01 EP disclosed
EP-2797938-A1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2014-11-05 EP disclosed
US-8841474-B2 Process for preparing 6-chlorodibenzo[D,F][1,3,2]dioxaphosphepin BASF SE (DE) 2014-09-23 US disclosed
WO-2013098371-A1 METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2013-07-04 WO disclosed
US-20130172596-A1 PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN BASF SE (DE) 2013-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172596-A1 PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN DCPS, PLCB3, DDT CYP2C9 672/4885CYP2C19 337/4885ALOX15 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.